1. Je majaribio ya chanjo ya ChAdOx1 nCOV-19 ni nini? Majaribio haya yanalenga kutathmini ikiwa chanjo ya ChAdOx1 nCOV-19 ni salama, inafanya kazi na inapeana kinga dhidi ya COVID-19 kwa watu wazima wenye umri wa miaka 18 na zaidi 2. Majaribio ya chanjo hii yatachukuwa muda gani? Baada ya kuanza, majaribio yatafanyika kwa muda wa miezi 24. […]

1. What is the ChAdOx1 Vaccine Trial? This trial aims to assess whether the ChAdOx1 vaccine is safe, effective and provides immunity against COVID-19 in adults aged 18 years and above. 2. How long will the vaccine trial run? After starting, the trial will run for 24 months. 3. Why conduct the trial in Kenya? A vaccine which […]

Health systems face persistent everyday challenges related to health system inputs/hardware (e.g. technology, infrastructure, funding, human resource) and processes/software (e.g. knowledge, decision-making processes, values, norms, relationships). These routine challenges are compounded by periodic shocks (e.g. disease outbreaks, industrial actions, etc.) to health system, making it important for health systems to build “everyday resilience”. Everyday resilience […]

Difu Simo is a mental health awareness campaign in Kilifi County that is using art to create a space for dialogue between the world of biomedicine and traditional medicines with the aim of understanding mental illness from a community perspective and addressing stigma. Difu Simo is a Kigiriama phrase which means “Breaking Free”. The campaign […]

Although health worker strikes are experienced globally, their effects have been argued to be the worst in lower- and middle-income countries (LMICs). Strike actions range from merely halting work for a few hours, through curtailing of non-critical services to complete stoppage of work. Health worker strikers elicit significant ethical debates, because of their ability to […]

In a recently published policy brief, Dr. Edwine Barasa and Dr. Angela Kairu costed the case management of COVID-19 patients from a health system perspective. Key messages from the policy brief • Per patient COVID-19 case management costs in hospitals are substantial ranging from KES 21,359   per day for asymptomatic patients, KES 21,361 per day for patients with […]

Join Dr. George Githinji and Dr. John Ojal  for a webinar on 24th July, 2020,  from 6pm – 7.30 pm as they discuss “The Role of SARS CoV-2 genomics in informing community transmission and public health decision making” and “Mathematical modelling for decision making in Kenya’s Covid-19 response”. Register here: https://t.co/P0EBp4lpBc?amp=1

Scientists in Kenya have successfully sequenced genomes of SARS-CoV-2, the virus responsible for the global COVID-19 pandemic, obtaining important information about the genetic composition of viral strains in 122 of the confirmed cases in Kenya. The scientists from Centre for Geographic Medicine Research-Coast (CGMR-C) and the KEMRI’s Centre for Virus Research (CVR) and in collaboration […]

Epidemics and pandemics disproportionately affect populations with greater impacts on the most vulnerable and less resilient communities. Hence Kenya’s response to the COVID-19 pandemic calls for more context adapted public health measures reflecting our improved understanding of who is the most vulnerable and their geographical location. This policy brief presents evidence on localized vulnerability indices […]

Malaria is common in sub-Saharan Africa and kills thousands of children yearly. Interferon-gamma is produced to help fight against malaria, but high levels can induce reduced production of blood cells resulting in anaemia. Anaemia negatively affects the development of children and can cause low productivity and fatigue. Interferon-gamma also affects pathways involved in dietary iron […]